Abstract:The human mycobiome encompasses diverse communities of fungal organisms residing within the body and has emerged as a critical player in shaping health and disease. While extensive research has focused on the skin and gut mycobiome, recent investigations have pointed toward the potential role of fungal organisms in neurological disorders. Among those fungal organisms, the presence of the commensal fungus Malassezia in the brain has created curiosity because of its commensal nature and primary association with the human skin and gut. This budding yeast is responsible for several diseases, such as Seborrheic dermatitis, Atopic dermatitis, Pityriasis versicolor, Malassezia folliculitis, dandruff, and others. However recent findings surprisingly show the presence of Malassezia DNA in the brain and have been linked to diseases like Alzheimer's disease, Parkinson's disease, Multiple sclerosis, and Amyotrophic lateral sclerosis. The exact role of Malassezia in these disorders is unknown, but its ability to infect human cells, travel through the bloodstream, cross the blood-brain barrier, and reside along with the lipid-rich neuronal cells are potential mechanisms responsible for pathogenesis. This also includes the induction of pro-inflammatory cytokines, disruption of the blood-brain barrier, gut-microbe interaction, and accumulation of metabolic changes in the brain environment. In this review, we discuss these key findings from studies linking Malassezia to neurological disorders, emphasizing the complex and multifaceted nature of these cases. Furthermore, we discuss potential mechanisms through which Malassezia might contribute to the development of neurological conditions. Future investigations will open up new avenues for our understanding of the fungal gut-brain axis and how it influences human behavior. Collaborative research efforts among microbiologists, neuroscientists, immunologists, and clinicians hold promise for unraveling the enigmatic connections between human commensal Malassezia and neurological disorders.

Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and animal skin

Cutaneous Malassezia: Commensal, Pathogen, or Protector?

Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals

Malassezia species in skin diseases

Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment

Malassezia spp. Yeasts of Emerging Concern in Fungemia

Overview of the Potential Role of Malassezia in Gut Health and Disease

Many ways, one microorganism: Several approaches to study Malassezia in interactions with model hosts

Malassezia Yeasts in Veterinary Dermatology: An Updated Overview

Approaches for Genetic Discoveries in the Skin Commensal and Pathogenic Malassezia Yeasts

Chronic Diseases Associated with Malassezia Yeast

Immunology of Diseases Associated with Malassezia Species

Skin Commensal Fungus Malassezia and Its Lipases

Malassezia‐associated skin diseases in the pediatric population

Seborrheic dermatitis-Looking beyond Malassezia

[Yeast-like fungi malassezia (pityrosporum): clinical and immunological aspects fo study]

From Skin and Gut to the Brain: The Infectious Journey of the Human Commensal Fungus Malassezia and Its Neurological Consequences

Fungal coexistence in the skin mycobiome: a study involving Malassezia, Candida, and Rhodotorula

S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation

Characteristics of Malassezia furfur at various pH and effects of Malassezia lipids on skin cells

More yeast, more problems?: reevaluating the role of Malassezia in seborrheic dermatitis